Clinical trial
An Investigational Drug in Patients With Osteoarthritis (0663-073)
NCT00092755 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092755 |
|---|---|
| Title | An Investigational Drug in Patients With Osteoarthritis (0663-073) |
| Official title | A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 2) |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | MK0663, etoricoxib, Comparators: ibuprofen and placebo |
| Enrollment | 548 |
| Start date | Apr 9, 2003 |
| Primary completion | Nov 13, 2003 |
| Completion | Nov 13, 2003 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: